News
COVID-19: How intensive care cardiology can inform the response
April 17, 2020
Cardiologists recommend adaptive staffing, organizational structure, medical treatment, and regional care pathways in the context of COVID-19.
![1]()
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
April 17, 2020
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
![1]()
News
Protean manifestations of COVID-19: “Our ignorance is profound”
April 17, 2020
“Make sure they didn’t die in vain.”
News
Evidence suggests possible RAS-blocker benefit in COVID-19 patients
April 16, 2020
Animal findings and physiologic mechanisms suggest RAS system inhibitors may benefit COVID-19 patients, another reason not to stop these drugs.
News
No hydroxychloroquine benefit in small, randomized COVID-19 trial
April 16, 2020
Two experts caution that because of confounding, the trial is unable to answer convincingly the question of whether HCQ can benefit COVID-19 patients.
![1]()
Opinion
COVID-19 mythconceptions
April 16, 2020
We are in a position where we need to take in what we can and assess the best data available.
![1]()
News
Sodium nitrite disappoints in cardiac arrest
April 16, 2020
The drug did not significantly improve patients’ chances of being admitted to or discharged from the hospital alive in a new study.
![1]()
News
COVID-19 cases highlight longstanding racial disparities in health care
April 16, 2020
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
News
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
April 14, 2020
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19,” a U.K. team argues.
![1]()
News
Cardiology groups push back on hydroxychloroquine, azithromycin for COVID-19
April 8, 2020
Both drugs are known to cause torsade de pointes and increase the risk of other arrhythmias, say the AHA, ACC, and HRS.
